ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells.
about
Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PEEpidermal growth factor mediates detachment from and invasion through collagen I and Matrigel in Capan-1 pancreatic cancer cellsPhosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?PTEN deficiency: a role in mammary carcinogenesis.Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancerTargeting mutants of PTEN reveal distinct subsets of tumour suppressor functionsRegulation of focal adhesion turnover by ErbB signalling in invasive breast cancer cells.Human epidermal growth factor receptor 2 and estrogen receptor status in respect to tumor characteristics in non-metastatic breast cancerThe oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisInhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formationTargeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer.Cooperative interactions of HER-2 and HPV-16 oncoproteins in the malignant transformation of human mammary epithelial cells.Integrin expression regulates neuroblastoma attachment and migrationGenes and pathways driving glioblastomas in humans and murine disease models.Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivoUrokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors.Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patientsCellular responses to ErbB-2 overexpression in human mammary luminal epithelial cells: comparison of mRNA and protein expression.Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer.Correlation between HER-2/neu(erbB-2) expression level and therapeutic effect of combination treatment with HERCEPTIN and chemotherapeutic agents in gastric cancer cell lines.Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors.p38MAPK induces cell surface alpha4 integrin downregulation to facilitate erbB-2-mediated invasion.Activation of the alpha2beta1 integrin prevents c-erbB2-induced scattering and apoptosis of human mammary epithelial cells in collagen.A bcl-xS adenovirus selectively induces apoptosis in transformed cells compared to normal mammary cells.Prognostic Impact of mRNA Expression Levels of HER1-4 (ERBB1-4) in Patients with Locally Advanced Rectal Cancer.Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin.Effects of ErbB-2 overexpression on mitogenic signalling and cell cycle progression in human breast luminal epithelial cells.EGFR and HER3 mRNA expression levels predict distant metastases in locally advanced rectal cancer.
P2860
Q24791357-385C7299-E22A-4326-A840-BFED6D168681Q24792963-881C528B-A3D0-42D7-B131-A18E85F90591Q24801684-1B879E6A-6380-4456-840E-3F8EA990E62BQ24801835-F902B772-7675-48D8-A44C-D623847C9771Q28259744-3824F25C-FC5E-46D0-AB96-6822A5049A2DQ28343581-147517F2-9406-4EAD-92BD-FF1EC920379DQ30486408-95AB0686-558C-4C0E-A639-55481A390D4CQ34126938-016AD06F-7DA2-40B8-A85D-0075B839BA43Q34493341-E1350E36-05FE-40B6-B95E-26B0264D2327Q34613650-A2F8B318-9D9B-46EF-8D48-9A14F4DB5877Q34649015-57FDC80D-EE97-4009-9D91-4B276B596A88Q34742858-7A47A2D8-A667-48F0-BA38-DC732FF26214Q34769657-1E28ADC4-57BD-49BB-B1A5-D4162A0768A7Q34770079-E85EC902-60E8-423D-B275-84F161DDCE68Q35143797-B380A8EF-2AF2-4450-A6A8-B593342A8B91Q36019387-5271A586-4A62-44CE-8B36-81F63D5D1511Q36393238-FAFF8F73-EE55-43B2-B0C7-1DB0048D2F4BQ36490382-7E18D991-A441-4C85-A540-5AAAB454C853Q36644036-11B7E78B-505C-4E51-B480-726902573F3DQ36673754-680B7CDD-BFAD-4F74-9F50-9CBA9CCD125DQ37001604-B24F6E6C-6AD5-416D-8C3D-EA21A3499E4DQ37559437-A9CC2CB4-A225-4C8D-96DA-67EAAC8312FAQ38161726-D3F38903-68EA-4767-9BB4-CE73FBD1FE8CQ40661252-F3B25CC2-AEAA-42F1-905E-B6A8E9B18DE8Q40849400-FB963BC0-E46D-4AC6-80FD-0BEC27DA9389Q40862926-595BA581-955D-45F0-833F-D90B82878A52Q40970786-6C290718-A339-4F32-B88C-F7CB3916DAD6Q51723599-205D4F44-A604-4E43-8D30-54444FBED359Q53386780-316C76B2-B442-4D85-9888-EEE9AD0B37A0Q54651225-B21FD838-7DA8-44D6-AD43-5A5C927BD48F
P2860
ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
ERBB-2 overexpression confers ...... uman mammary epithelial cells.
@ast
ERBB-2 overexpression confers ...... uman mammary epithelial cells.
@en
type
label
ERBB-2 overexpression confers ...... uman mammary epithelial cells.
@ast
ERBB-2 overexpression confers ...... uman mammary epithelial cells.
@en
prefLabel
ERBB-2 overexpression confers ...... uman mammary epithelial cells.
@ast
ERBB-2 overexpression confers ...... uman mammary epithelial cells.
@en
P2093
P2860
P356
P1476
ERBB-2 overexpression confers ...... uman mammary epithelial cells.
@en
P2093
D L Livant
K M Ignatoski
S M Markwart
S P Ethier
P2860
P2888
P304
P356
10.1054/BJOC.1999.0979
P407
P577
2000-02-01T00:00:00Z
P5875
P6179
1035784313